AXQ Capital LP Buys 12,493 Shares of Encompass Health Corporation $EHC

AXQ Capital LP grew its stake in Encompass Health Corporation (NYSE:EHC) by 416.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 15,495 shares of the company’s stock after purchasing an additional 12,493 shares during the quarter. AXQ Capital LP’s holdings in Encompass Health were worth $1,645,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the stock. BNP Paribas Financial Markets lifted its holdings in shares of Encompass Health by 2.1% in the fourth quarter. BNP Paribas Financial Markets now owns 66,161 shares of the company’s stock valued at $7,022,000 after purchasing an additional 1,358 shares in the last quarter. Norges Bank purchased a new stake in shares of Encompass Health during the fourth quarter valued at approximately $133,221,000. Eurizon Capital SGR S.p.A. purchased a new stake in shares of Encompass Health during the fourth quarter valued at approximately $143,000. Savant Capital LLC increased its position in shares of Encompass Health by 44.8% during the fourth quarter. Savant Capital LLC now owns 5,162 shares of the company’s stock valued at $548,000 after acquiring an additional 1,597 shares during the last quarter. Finally, Intech Investment Management LLC increased its position in shares of Encompass Health by 505.6% during the fourth quarter. Intech Investment Management LLC now owns 132,225 shares of the company’s stock valued at $14,034,000 after acquiring an additional 110,393 shares during the last quarter. Institutional investors own 97.25% of the company’s stock.

Analyst Upgrades and Downgrades

EHC has been the subject of a number of research analyst reports. Wall Street Zen raised Encompass Health from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Leerink Partners set a $152.00 price target on Encompass Health in a research report on Friday, May 22nd. TD Cowen initiated coverage on Encompass Health in a research report on Thursday. They set a “buy” rating and a $125.00 price target for the company. Finally, Barclays decreased their price target on Encompass Health from $153.00 to $140.00 and set an “overweight” rating for the company in a research report on Tuesday, May 5th. Two investment analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, Encompass Health has an average rating of “Buy” and an average target price of $142.75.

Insider Buying and Selling at Encompass Health

In related news, Treasurer Edmund Fay sold 11,937 shares of Encompass Health stock in a transaction on Monday, March 9th. The stock was sold at an average price of $107.00, for a total transaction of $1,277,259.00. Following the completion of the sale, the treasurer owned 89,325 shares of the company’s stock, valued at approximately $9,557,775. This trade represents a 11.79% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Patrick William Tuer sold 682 shares of Encompass Health stock in a transaction on Monday, May 11th. The shares were sold at an average price of $104.56, for a total value of $71,309.92. Following the sale, the executive vice president directly owned 24,755 shares of the company’s stock, valued at $2,588,382.80. This represents a 2.68% decrease in their position. The disclosure for this sale is available in the SEC filing. 1.80% of the stock is currently owned by insiders.

Encompass Health Price Performance

Shares of NYSE EHC opened at $102.60 on Tuesday. The stock has a market cap of $10.18 billion, a PE ratio of 17.13, a price-to-earnings-growth ratio of 2.31 and a beta of 0.72. Encompass Health Corporation has a fifty-two week low of $92.77 and a fifty-two week high of $127.99. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.17 and a current ratio of 1.17. The stock has a fifty day moving average of $103.40 and a 200-day moving average of $105.28.

Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Thursday, April 30th. The company reported $1.60 earnings per share for the quarter, beating the consensus estimate of $1.51 by $0.09. The company had revenue of $1.59 billion during the quarter, compared to analysts’ expectations of $1.57 billion. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The firm’s quarterly revenue was up 9.0% compared to the same quarter last year. During the same period in the previous year, the business earned $1.37 earnings per share. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. Equities research analysts anticipate that Encompass Health Corporation will post 5.96 earnings per share for the current year.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be given a $0.19 dividend. The ex-dividend date is Wednesday, July 1st. This represents a $0.76 annualized dividend and a dividend yield of 0.7%. Encompass Health’s payout ratio is 12.69%.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.